ÃÖÁ¾ ¾ÆÁ¨´Ù ÀÌ¿ë °¡´É
Drug Discovery Chemistry´Â Á¦¾à ±â¾÷¡¤¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷¡¤Çа迡 Á¾»çÇÏ´Â ÀǾàÈÇÐÀÚ¡¤»ý¹° ¹°¸®ÈÇÐÀÚ¸¦ À§ÇÑ ¿ªµ¿ÀûÀÎ ÄÁÆÛ·±½ºÀÔ´Ï´Ù. ÀúºÐÀÚ ÀǾàÇ° Èĺ¸ÀÇ ¹ß°ß°ú ÃÖÀûÈ ¹®Á¦¿¡ ÃÊÁ¡À» ¸ÂÃß°í, ¸¹Àº Èï¹Ì·Î¿î ±âȸ°¡ Á¦°øµÇ¹Ç·Î µ¿½Ã ÁøÇà Æ®·¢À» ¿À°¡¸ç ÀÚ½ÅÀÇ °ü½É»ç¿¡ °¡Àå ÀûÇÕÇÑ ÇÁ·¹Á¨Å×À̼ÇÀ» µéÀ» ¼ö ÀÖ´Â °íÀ¯ ÇÁ·Î±×·¥À» ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÛ³â À̺¥Æ®´Â ¿ª´ë ÃÖ´ë ±Ô¸ð¿´½À´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¾Æ·¡ Ãßõ ¿µ»ó ¹× Æ÷Åä °¶·¯¸®¸¦ ÂüÁ¶ÇϽñ⠹ٶø´Ï´Ù.
¾÷°è ¿¬»ç : AbbVie, Amgen, Astex Pharmaceuticals, AstraZeneca, Bayer, Biogen, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, Genentech, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi µî
2025³â Ç÷¹³Ê¸® ±âÁ¶ °¿¬
Applying Diverse Small Molecule Strategies to Difficult Targets: Drugging BTK for (Neuro)Immunology
Christopher J. Helal, PhD
Vice President & Head, Medicinal Chemistry, Biogen
Simplifying Synthesis with Radicals
Phil Baran, PhD
Chair & Professor, Department of Chemistry, Scripps Research Institute
À̺¥Æ® ¼Ò°³
Drug Discovery Chemistry´Â ÀúºÐÀÚ ÀǾàÇ° Èĺ¸ÀÇ ¹ß°ß°ú ÃÖÀûÈ ¹®Á¦¿¡ ÃÊÁ¡À» ¸ÂÃß°í, Á¦¾à ±â¾÷¡¤¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷¡¤Çа迡 Á¾»çÇÏ´Â ÀǾàÈÇÐÀÚ¡¤»ý¹° ¹°¸®ÈÇÐÀÚ¸¦ À§ÇÑ ¿ªµ¿ÀûÀÎ ÄÁÆÛ·±½º·Î, ´ÙÀ½°ú °°Àº Ư¡ÀÌ ÀÖ½À´Ï´Ù.